Keyphrases
Meta-analysis
100%
Randomized Controlled Trial
100%
Clinical Analysis
100%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
100%
Vasospasm
100%
Cerebral Vasospasm
40%
Significant Benefit
40%
Nimodipine
40%
National Institutes of Health
20%
Clinical Trials
20%
Treatment Options
20%
MEDLINE
20%
Statins
20%
Cochrane
20%
Successful Treatment
20%
Literature Search
20%
Search Terms
20%
Multicenter Randomized Controlled Trial
20%
Clinical Trial Registry
20%
Neurological Outcome
20%
Calcium Channel Blockers
20%
U.S. National Library of Medicine
20%
Search Criteria
20%
Antifibrinolytics
20%
Trial Registries
20%
Therapeutic Modalities
20%
Nicardipine
20%
Magnesium
20%
Free Radical Scavenger
20%
Endothelin Receptor Antagonist
20%
Delayed Ischemic Neurological Deficit
20%
Plain Balloon Angioplasty
20%
Tirilazad
20%
Fasudil
20%
Triple-H Therapy
20%
Medicine and Dentistry
Randomized Controlled Trial
100%
Meta-Analysis
100%
Subarachnoid Hemorrhage
100%
Vasospasm
100%
Clinical Trial
40%
Brain Vasospasm
40%
Nimodipine
40%
Percutaneous Transluminal Angioplasty
20%
Medicine
20%
Statin
20%
Calcium Channel Blocking Agent
20%
Therapeutic Modality
20%
Thrombolytic Drug
20%
Antifibrinolytic
20%
Nicardipine
20%
Magnesium
20%
Endothelin Receptor Antagonist
20%
Scavenger
20%
Tirilazad
20%
Fasudil
20%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Subarachnoid Hemorrhage
100%
Vasospasm
100%
Clinical Trial
40%
Nimodipine
40%
Brain Vasospasm
40%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Fibrinolytic Agent
20%
Calcium Channel Blocker
20%
Endothelin Receptor Antagonist
20%
Scavenger
20%
Antifibrinolytic Agent
20%
Nicardipine
20%
Fasudil
20%
Tirilazad
20%
Neuroscience
Meta-Analysis
100%
Randomized Controlled Trial
100%
Subarachnoid Hemorrhage
100%
Vasospasm
100%
Nimodipine
40%
Statin
20%
Free Radical
20%
Thrombolytic Drug
20%
Endothelin Receptor Antagonist
20%
Fasudil
20%
Antifibrinolytic
20%
Calcium Channel Blocker
20%
Nicardipine
20%